Read our Latest Expert Industry Insights

Anonymisation and pseudonymisation are two key concepts for the General Data Protection Regulation (GDPR). The GDPR provides exceptions to many of the most burdensome provisions of the regulation when steps are taken to de-identify personal data using anoymisation or pseudonymisation.

MDR will have a big impact on the eHealth market. Suddenly, software is being treated as a medical device. Here we look at how MDR affects your choice of cloud provider.

The new MDR becomes mandatory from 2020. Many eHealth applications will now be classed as medical devices. Here we discuss how MDR is related to GDPR and how they impact application development.

Potentially sensitive data, such as that generated by wellbeing apps, is a "grey area” where the GDPR classification is open for interpretation.

If data is in any way identifiable or can be connected to the user (directly or indirectly), the data collection process cannot make the claim of being anonymous.

Under GDPR law, sensitive data is in a much higher risk category than other types of personal data. Businesses that store sensitive health data should focus on GDPR administrative and technical recuirenments.

GDPR fines are starting to bite. Find out about 3 of the most recent rulings from across Europe. Then read the 7 most important lessons the fines teach us.

Every **Digital Health App** processes **personal data** and most will also process health sensitive data. Processing such data requires you to be compliant with relevant data protection laws. How do you do that as a Digital Health Business? Here are the key things you have to consider.

As 2018 goes to the end, we reflect on our accomplishments. Now we are the only ISO 13485 certified Database as a Service (DBaaS) for Medical Data. Meaning that our customers cut time to market, costs, and eliminate risks related to health sensitive data management.